Lorraine Kelley-Quon, MD, MSHS, FACS, FAAP News

Senior Program Manager Casey Covarrubias discusses the services offered through the program, which supports junior researchers with their NIH grant applications.

Screening for substance abuse in the emergency department can flag at-risk adolescents who need interventions, but not everyone gets screened.

Two CHLA experts explain the steps parents should take to protect their kids from ingesting potentially toxic prescription drugs.

CHLA’s opioid take-back day provides families a safe way to discard their unused prescription drugs and protect their kids from potential harm.

Dr. Keane is a Postdoctoral Fellow studying the impact of cumulative opioid exposure on a baby’s brain development.

Regional and institutional variations in duration of opioid treatment for infants underscore need for national standards.

Dr. Barq is a Postdoctoral Research Fellow investigating how hospital opioid exposures impact infants’ brain development.

Large clinical trial to study safest and most effective pain medications for adolescents and young adults following common surgeries.

As a pediatric surgeon at CHLA, Dr. Kelley-Quon enjoys making a lifesaving impact on individual families. But it’s through research that she has broadened her reach.